Frizzled 2 (FZD2) Antibody
416€ (200 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Frizzled 2 (FZD2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx432024
tested applications
P-ELISA, WB, IHC, IF/ICC
Description
Frizzled 2 Antibody is a Goat Polyclonal antibody against Frizzled 2.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Frizzled 2 (FZD2) |
| Host | Goat |
| Reactivity | Human |
| Recommended Dilution | P-ELISA: 1/64000. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Size 1 | 200 µl |
| Form | Liquid |
| Tested Applications | P-ELISA, WB, IHC, IF/ICC |
| Buffer | Tris saline, pH 7.3, containing 0.02% sodium azide and 0.5% bovine serum albumin. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Gene ID | 2535, 57265, 64512 |
| NCBI Accession | NP_001457.1 |
| Alias | FDZ2,Fz2,Frizzled-2,frizzled family receptor 2,Fzd10,Fz10,fz-2,fzE2,hFz2,OMOD2 |
| Background | Antibody anti-FZD2 |
| Status | RUO |
| Note | Concentration: 0.5 mg/ml - |
Descripción
FZD2 is a G protein-coupled receptor that binds Wnt ligands, mediating both canonical (β-catenin-dependent) and non-canonical (PCP and calcium) Wnt signaling pathways. It is expressed in various tissues, including the heart, lung, and skeletal system, where it regulates embryonic development, tissue remodeling, and cellular signaling. FZD2 plays a critical role in cell migration and polarity during embryogenesis, particularly in neural tube closure, heart development, and limb patterning. In cancer, FZD2 is upregulated in tumors such as gastric, liver, and lung cancers, where it enhances epithelial-mesenchymal transition (EMT), cell invasion, and metastasis through Wnt/β-catenin-independent pathways. FZD2 has also been implicated in fibrosis, including pulmonary and hepatic fibrosis, where its activation drives myofibroblast differentiation and excessive extracellular matrix production. Dysregulation of FZD2 signaling contributes to developmental abnormalities and chronic diseases. Pharmacological targeting of FZD2 offers therapeutic potential in cancer and fibrotic diseases by inhibiting aberrant Wnt signaling and EMT processes. Its role in cellular polarity and migration underscores its importance in both normal development and disease progression.
Related Products
FZD2 antibody
Ver Producto
Frizzled Homolog 2 (FZD2) Antibody
Rabbit polyclonal antibody against FZD2 protein. Immunogen region is Internal.
Ver Producto